<SEC-DOCUMENT>0001104659-20-004738.txt : 20200116
<SEC-HEADER>0001104659-20-004738.hdr.sgml : 20200116
<ACCEPTANCE-DATETIME>20200116160938
ACCESSION NUMBER:		0001104659-20-004738
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20200112
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200116
DATE AS OF CHANGE:		20200116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INCYTE CORP
		CENTRAL INDEX KEY:			0000879169
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				943136539
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12400
		FILM NUMBER:		20531028

	BUSINESS ADDRESS:	
		STREET 1:		1801 AUGUSTINE CUT-OFF
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19803
		BUSINESS PHONE:		3024986700

	MAIL ADDRESS:	
		STREET 1:		1801 AUGUSTINE CUT-OFF
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19803

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INCYTE CORP
		DATE OF NAME CHANGE:	20030318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INCYTE GENOMICS INC
		DATE OF NAME CHANGE:	20000710

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INCYTE PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19930902
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm203494-1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:incy="http://incyte.com/20200112">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" /></head>
<!-- Field: Set; Name: xdx; ID: xdx_021_US%2DGAAP%2D2019 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_incy_incyte.com_20200112 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20200111_20200112_zG64ErlfrfJd -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000879169 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:EntityCentralIndexKey">0000879169</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="incy-20200112.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-01-11to2020-01-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000879169</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-11</xbrli:startDate>
        <xbrli:endDate>2020-01-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_903_edei--DocumentType_c20200111__20200112_zJsvgDqMPcZi"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)&#160;of
the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):&#160;
<b><span id="xdx_903_edei--DocumentPeriodEndDate_c20200111__20200112_zJlcmGuJ9443"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January 12, 2020</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityRegistrantName_c20200111__20200112_zQOaYn9ofeAd"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:EntityRegistrantName">INCYTE CORPORATION</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20200111__20200112_zWzvKZBWZxrk"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span><br />
(State or Other Jurisdiction of<br /> Incorporation)</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityFileNumber_c20200111__20200112_zl0HzTRLrKh"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:EntityFileNumber">001-12400</ix:nonNumeric></span></b></span><br />
(Commission File Number)</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20200111__20200112_zimOWedVhlQ4"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:EntityTaxIdentificationNumber">94-3136539</ix:nonNumeric></span></b></span><br />
(I.R.S. Employer<br /> Identification No.)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 50%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20200111__20200112_z3rXAWH7Vhd"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:EntityAddressAddressLine1">1801 Augustine Cut-Off</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 49%; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20200111__20200112_zfvFjiJlN8W2"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:EntityAddressCityOrTown">Wilmington</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20200111__20200112_zEerOUKPSfRl"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:EntityAddressStateOrProvince">DE</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityAddressPostalZipCode_c20200111__20200112_zDbqnjmXPXif"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:EntityAddressPostalZipCode">19803</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90F_edei--CityAreaCode_c20200111__20200112_z1ZAgVQO7VOd"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:CityAreaCode">302</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20200111__20200112_zdcn5rexgBnk"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:LocalPhoneNumber">498-6700</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number,<br />
including area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form&#160;8-K filing
is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0 0pt 13.5pt; font-size: 10pt; text-indent: -13.5pt"><span style="font-family: Wingdings"><span id="xdx_902_edei--WrittenCommunications_c20200111__20200112_zulEV7UuGbge"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;
</span>Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0 0pt 13.5pt; font-size: 10pt; text-indent: -13.5pt"><span style="font-family: Wingdings"><span id="xdx_90F_edei--SolicitingMaterial_c20200111__20200112_zX9ec5XJ0AWg"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;
</span>Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0 0pt 13.5pt; font-size: 10pt; text-indent: -13.5pt"><span style="font-family: Wingdings"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20200111__20200112_zA21w9OY6Yy9"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;
</span>Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0 0pt 13.5pt; font-size: 10pt; text-indent: -13.5pt"><span style="font-family: Wingdings"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20200111__20200112_zTVVusJpPpG5"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;
</span>Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240-13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Securities registered pursuant to Section&#160;12(b)&#160;of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title&#160;of&#160;each&#160;class</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading&#160;symbol(s)&#160;</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--Security12bTitle_c20200111__20200112_zJaIAonNEP21"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:Security12bTitle">Common Stock, $.001 par value per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_c20200111__20200112_zCME2uZyjUR8"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" name="dei:TradingSymbol">INCY</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--SecurityExchangeName_c20200111__20200112_zS7N90sebWZb"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule&#160;12b&#8211;2
of the Securities Exchange Act of 1934 (&#167;240.12b&#8211;2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: right; font-size: 10pt; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth company&#160;&#160; <span style="font-family: Wingdings"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20200111__20200112_zeRpGQYzF9I4"><ix:nonNumeric contextRef="From2020-01-11to2020-01-12" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font-size: 10pt; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange
Act.&#160; <span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><b>Item 1.01 &#160;&#160;Entry Into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">On January 12, 2020, Incyte
Corporation (the &#8220;Company&#8221;) entered into a Collaboration and License Agreement (the &#8220;Collaboration Agreement&#8221;)
with MorphoSys AG and MorphoSys US Inc., a wholly-owned subsidiary of MorphoSys AG (together with MorphoSys AG, &#8220;MorphoSys&#8221;),
covering the worldwide development and commercialization of MOR208 (tafasitamab). Tafasitimab is an investigational monoclonal
antibody directed against the target molecule CD19 that is currently in clinical development by MorphoSys. MorphoSys has exclusive
worldwide development and commercialization rights to tafasitamab under a June 2010 collaboration and license agreement with Xencor,
Inc. In December 2019, MorphoSys submitted a Biologics License Application to the U.S. Food and Drug Administration for tafasitamab
for the treatment of relapsed or refractory diffuse large B cell lymphoma.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Under the terms of the
Collaboration Agreement, the Company will receive exclusive commercialization rights outside of the United States, and MorphoSys
and the Company will have co-commercialization rights in the United States, with respect to tafasitamab. MorphoSys will be responsible
for leading commercialization strategy and booking all revenue from sales of tafasitamab in the United States, and the Company
and MorphoSys will both be responsible for commercialization efforts in the United States and will share equally the profits and
losses from the co-commercialization efforts. The Company will lead the commercialization strategy outside of the United States,
and will be responsible for commercialization efforts and book all revenue from sales of tafasitamab outside of the United States,
subject to the Company&#8217;s royalty payment obligations set forth below. The Company and MorphoSys have agreed to co-develop
tafasitamab and to share development costs associated with global and U.S.-specific clinical trials, with the Company responsible
for 55% of such costs and MorphoSys responsible for 45% of such costs. Each company will be responsible for funding any independent
development activities, and the Company will be responsible for funding development activities specific to its territory. All development
costs related to the collaboration will be subject to a joint development plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Company has agreed
to pay MorphoSys an upfront non-refundable payment of $750 million. MorphoSys will be eligible to receive up to $740 million in
future contingent development and regulatory milestones and up to $315 million in commercialization milestones as well as tiered
royalties ranging from the mid-teens to mid-twenties of net sales outside of the United States. MorphoSys&#8217; right to receive
royalties in any particular country will expire upon the last to occur of (a) the expiration of patent rights in that particular
country, (b) a specified period of time after the first post-marketing authorization sale of a licensed product comprising tafasitamab
in that country, and (c) the expiration of any regulatory exclusivity for that licensed product in that country.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Collaboration Agreement
includes various representations, warranties, covenants, indemnities and other provisions customary for transactions of this nature.
The Collaboration Agreement will continue until the termination of the Collaboration Agreement in accordance with its terms. The
Collaboration Agreement may be terminated, following a specified time period of multiple years, by the Company for convenience,
subject to a specified notice period. The Collaboration Agreement may also be terminated by either party under certain other circumstances,
including material breach, as set forth in the Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The effectiveness of the
Collaboration Agreement is conditioned on the early termination or expiration of the waiting period under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976 as well as clearance by the German and Austrian antitrust authorities; however, certain confidentiality
and antitrust filing provisions became effective upon execution of the Collaboration Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In addition, under the
Collaboration Agreement and pursuant to a related purchase agreement (the &#8220;Purchase Agreement&#8221;), the Company has agreed
to purchase American Depositary Shares (&#8220;ADSs&#8221;), each representing 0.25 of an ordinary share of MorphoSys AG, for an
aggregate purchase price of $150 million (such ADSs to be purchased, the &#8220;New ADSs&#8221;). The actual number of New ADSs
to be purchased will be determined by reference to the market price of the ADSs around the time of issuance and the price per New
ADS will represent a premium to the market price of the ADSs on the execution date of the Collaboration Agreement. Under the Purchase
Agreement, the Company has agreed, subject to limited exceptions, not to sell or otherwise transfer any of the New ADSs for an
18-month period. Closing of the purchase of the New ADSs is subject to customary conditions, as well as the effectiveness of the
Collaboration Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The foregoing descriptions
of the Collaboration Agreement and Purchase Agreement do not purport to be complete and are qualified in their entirety by reference
to such agreements, copies of which the Company expects to file as exhibits to the Company&#8217;s Quarterly Report on Form 10-Q
for the quarter ending March 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Item 7.01&#160;&#160; Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On January 13, 2020, the Company and MorphoSys
issued a press release relating to the Collaboration Agreement. A copy of the press release is furnished herewith as Exhibit 99.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><b>Item 9.01&#160;&#160; Financial Statements
and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td><a href="tm203494d1_ex99-1.htm" style="-sec-extract: exhibit">99.1</a></td>
    <td style="font-size: 10pt"><a href="tm203494d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font: 10pt Times New Roman, Times, Serif">Press release issued by Incyte Corporation and MorphoSys AG dated January 13, 2020.</span></a></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">104</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Cover Page Interactive
    Data File (embedded within the Inline XBRL document).</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.5in">Dated: January 16, 2020</td>
    <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td colspan="2" style="text-align: left">INCYTE CORPORATION</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; width: 52%">&#160;</td>
    <td style="text-align: left; width: 2%">By:&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 46%">/s/ Maria E. Pasquale</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: center">Maria E. Pasquale</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: center">Executive Vice President and</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: center">General Counsel</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 4; Options: NewSection Last; Value: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>



</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm203494d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"><IMG SRC="tm203494d1_ex99-1img002.jpg" ALT=""></TD><TD STYLE="text-align: right; width: 50%">&nbsp;<IMG SRC="tm203494d1_ex99-1img001.jpg" ALT=""></TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Release</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Planegg/Munich, Germany, and Wilmington, Delaware, U.S., January
13, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MorphoSys and Incyte Sign Global Collaboration
and License Agreement for Tafasitamab </B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> - <I>MorphoSys and Incyte to co-commercialize tafasitamab in the U.S.</I></P>



<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <I>Incyte has exclusive commercialization
rights outside of the U.S.</I></P>



<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">- <I>MorphoSys and Incyte to host joint
conference call on January 13, 2020 at 7:00am PST / 4:00pm CET </I></P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MorphoSys AG (FSE: MOR; Prime Standard
Segment; MDAX &amp; TecDAX; NASDAQ: MOR) and Incyte Corporation (NASDAQ: INCY) announced today that the companies have entered
into a collaboration and license agreement to further develop and commercialize MorphoSys&rsquo; proprietary anti-CD19 antibody
tafasitamab (MOR208) globally. Tafasitamab is an Fc-engineered antibody against CD19 currently in clinical development for the
treatment of B cell malignancies. MorphoSys and Incyte will co-commercialize tafasitamab in the U.S., while Incyte has exclusive
commercialization rights outside of the U.S.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;The global partnership with Incyte
is an important step towards unlocking the full potential of tafasitamab and achieving our goal of rapidly bringing tafasitamab
to patients inside and outside of the U.S.,&rdquo; said Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys. &ldquo;The
combination of our strong antibody and drug development expertise partnered with Incyte&rsquo;s well-established hematology-oncology
experience and their commercial operations in key territories has the potential to significantly broaden the tafasitamab opportunity.
We are pleased to work with Incyte to jointly improve the lives of patients suffering from DLBCL and other devastating diseases.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Bringing together Incyte&rsquo;s
expertise and MorphoSys&lsquo; commitment to innovation will allow us to make tafasitamab widely available to patients with cancer,
upon approval,&rdquo; said Herv&eacute; Hoppenot, CEO of Incyte. &ldquo;We look forward to collaborating closely with the team
at MorphoSys and adding tafasitamab to our portfolio of oncology candidates as part of our committment to bringing new, advanced
treatment options to patients and the clinical community around the world.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the agreement, MorphoSys
will receive an upfront payment of $750 million and, in addition, Incyte will make an equity investment into MorphoSys of $150
million in new American Depositary Shares (ADS) of MorphoSys at a premium to the share price at signing of the agreement. Depending
on the achievement of certain developmental, regulatory and commercial milestones, MorphoSys will be eligible to receive milestone
payments amounting to up to $1.1 billion. MorphoSys will also receive tiered royalties on ex-U.S. net sales of tafasitamab in a
mid-teens to mid-twenties percentage range of net sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the U.S., MorphoSys and Incyte will
co-commercialize tafasitamab, with MorphoSys leading the commercialization strategy and booking all revenues from sales of tafasitamab.
Incyte and MorphoSys will be jointly responsible for commercialization activities in the U.S. and will share profits and losses
on a 50:50 basis. Outside the U.S., Incyte will have exclusive commercialization rights, and will lead the commercialization strategy
and book all revenues from sales of tafasitamab, paying MorphoSys royalties on ex-U.S. net sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 5</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, the companies will share development
costs associated with global and U.S.-specific trials at a rate of 55% (Incyte) to 45% (MorphoSys); Incyte will cover 100% of the
future development costs for trials that are specific to ex-U.S. countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Both parties have agreed to co-develop
tafasitamab broadly in relapsed/refractory diffuse large B cell lymphoma (r/r DLBCL), frontline DLBCL as well as additional indications
beyond DLBCL, such as follicular lymphoma (FL), marginal zone lymphoma (MZL) and chronic lymphocytic leukemia (CLL). Incyte will
be responsible for initiating a combination study of its investigational PI3K-delta inhibitor parsaclisib and tafasitamab in r/r
B cell malignancies. Further, Incyte will be responsible for leading any potential registration-enabling studies in CLL and a phase
3 trial in r/r FL/MZL. MorphoSys will continue to be responsible for its currently ongoing clinical trials of tafasitamab in non-Hodgkin
lymphoma (NHL), CLL, r/r DLBCL and frontline DLBCL. The parties will share responsibility in starting additional global trials,
and Incyte intends to pursue development in additional territories including Japan and China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MorphoSys recently submitted a Biologics
License Application (BLA) for tafasitamab, in combination with lenalidomide, to the U.S. Food and Drug Administration (FDA) for
the treatment of r/r DLBCL; the FDA decision regarding a potential approval is expected by mid-2020. The submission of a Marketing
Authorization Application (MAA) to the European Medicines Agency (EMA) in r/r DLBCL is planned for mid-2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The agreement between MorphoSys and Incyte,
including the equity investment, is subject to clearance by the U.S. antitrust authorities under the Hart-Scott-Rodino Act as well
as by the German and Austrian antitrust authorities, and will become effective as soon as these conditions have been met.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MorphoSys and Incyte will host a joint
conference call on January 13, 2020 at 7:00am PST/ 4:00pm CET.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dial-in numbers for the conference call
on Monday, January 13, 2020 at 7:00am PST; 3:00pm GMT; 10:00am EST; 04:00pm CET:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For Germany:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+49 69 201 744 220</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the U.K.:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+44 203 009 2470</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the U.S.:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+1 877 423 0830</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Participant PIN:&nbsp;&nbsp;&nbsp;55656540#</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please dial in 10 minutes before the beginning
of the conference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A live webcast will be made available
at <U>www.morphosys.com</U> and at <U>investor.incyte.com</U><FONT STYLE="color: blue">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 5</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>About Tafasitamab</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tafasitamab is an investigational humanized
Fc-engineered monoclonal antibody directed against CD19. In 2010, MorphoSys licensed exclusive worldwide rights to develop and
commercialize tafasitamab from Xencor, Inc. Tafasitamab incorporates an XmAb<SUP>&reg;</SUP> engineered Fc domain, which is intended
to lead to a significant potentiation of antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis
(ADCP), thus aiming to improve a key mechanism of tumor cell killing. MorphoSys is clinically investigating tafasitamab as a therapeutic
option in B cell malignancies in a number of ongoing combination trials. An open-label phase 2 combination trial (L-MIND study)
is investigating the safety and efficacy of tafasitamab in combination with lenalidomide in patients with relapsed/refractory DLBCL
who are not eligible for high-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT). Based on interim data from
L-MIND, in October 2017 the U.S. FDA granted Breakthrough Therapy Designation for tafasitamab plus lenalidomide in this patient
population. Re-MIND, the real-world data lenalidomide alone matched control cohort met its primary endpoint in October 2019, demonstrating
clinical superiority of the tafasitamab/lenalidomide combination compared to lenalidomide alone. The ongoing phase 3 study B-MIND
assesses the combination of tafasitamab and bendamustine versus rituximab and bendamustine in r/r DLBCL. In addition, tafasitamab
is currently being investigated in patients with relapsed/refractory CLL/SLL after discontinuation of a prior Bruton tyrosine kinase
(BTK) inhibitor therapy (e.g. ibrutinib) in combination with idelalisib or venetoclax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>About MorphoSys</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MorphoSys (FSE &amp; NASDAQ: MOR) is a
clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of exceptional, innovative
therapies for patients suffering from serious diseases. The focus is on cancer. Based on its leading expertise in antibody, protein
and peptide technologies, MorphoSys, together with its partners, has developed and contributed to the development of more than
100 product candidates, of which 28 are currently in clinical development. In 2017, Tremfya<SUP>&reg;</SUP>, marketed by Janssen
for the treatment of plaque psoriasis, became the first drug based on MorphoSys&rsquo;s antibody technology to receive regulatory
approval. The Company&rsquo;s most advanced proprietary product candidate, tafasitamab (MOR208), has been granted U.S. FDA breakthrough
therapy designation for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Headquartered
near Munich, Germany, the MorphoSys group, including the fully owned U.S. subsidiary MorphoSys US Inc., has approximately 405
employees. More information at <U>https://www.morphosys.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">HuCAL<SUP>&reg;</SUP>, HuCAL GOLD<SUP>&reg;</SUP>,
HuCAL PLATINUM<SUP>&reg;</SUP>, CysDisplay<SUP>&reg;</SUP>, RapMAT<SUP>&reg;</SUP>, arYla<SUP>&reg;</SUP>, Ylanthia<SUP>&reg;</SUP>,
100 billion high potentials<SUP>&reg;</SUP>, Slonomics<SUP>&reg;</SUP>, Lanthio Pharma<SUP>&reg;</SUP>, LanthioPep<SUP>&reg;</SUP>
and ENFORCER<SUP>TM</SUP> are trademarks of the MorphoSys Group. Tremfya<SUP>&reg;</SUP> is a trademark of Janssen Biotech, Inc.
XmAb<SUP>&reg;</SUP> is a trademark of Xencor, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>About Parsaclisib</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Parsaclisib (INCB50465) is a highly selective
and potent inhibitor of the phosphatidylinositol 3-kinase delta (PI3K&delta;) isoform. PI3K&delta; is an important target implicated
in malignant B-cell growth, survival and proliferation, and its inhibition has potential as a mechanism to treat hematologic malignancies
and a variety of B-cell mediated and antibody-driven diseases beyond oncology. The CITADEL&nbsp;(Clinical Investigation of TArgeted
PI3K-DELta Inhibition in Lymphomas) clinical trial program is currently evaluating parsaclisib in several ongoing Phase 2 trials
as a treatment for non-Hodgkin lymphomas (follicular, marginal zone and mantle cell). Parsaclisib is also being studied for patients
with autoimmune hemolytic anemia and as part of a combination therapy for patients with myeloproliferative neoplasms and non-Hodgkin
lymphomas including diffuse large B-cell lymphoma.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>About Incyte Corporation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Incyte&nbsp;is a&nbsp;Wilmington, Delaware-based,
global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development
and commercialization of proprietary therapeutics. For additional information on&nbsp;Incyte, please visit Incyte.com and follow
@Incyte.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 5</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>MorphoSys forward looking statements</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>This communication
contains certain forward-looking statements concerning the MorphoSys group of companies, including the expectations regarding the
licensing agreement for tafasitamab, the further clinical development of tafasitamab</I></FONT>, <FONT STYLE="font-size: 10pt"><I>interactions
with regulatory authorities and expectations regarding regulatory filings and possible approvals for tafasitamab as well as the
potential future commercialization of tafasitamab. The forward-looking statements contained herein represent the judgment of MorphoSys
as of the date of this release and involve known and unknown risks and uncertainties, which might cause the actual results, financial
condition and liquidity, performance or achievements of MorphoSys, or industry results, to be materially different from any historic
or future results, financial conditions and liquidity, performance or achievements expressed or implied by such forward-looking
statements. In addition, even if MorphoSys' results, performance, financial condition and liquidity, and the development of the
industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments
in future periods. Among the factors that may result in differences are MorphoSys' expectations regarding the licensing agreement
for tafasitamab, the further clinical development of tafasitamab, interactions with regulatory authorities and expectations regarding
regulatory filings and possible approvals for tafasitamab as well as the potential future commercialization of tafasitamab, MorphoSys'
reliance on collaborations with third parties, estimating the commercial potential of its development programs and other risks
indicated in the risk factors included in MorphoSys&rsquo;s Annual Report on Form 20-F and other filings with the US Securities
and Exchange Commission. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking
statements. These forward-looking statements speak only as of the date of publication of this document. MorphoSys expressly disclaims
any obligation to update any such forward-looking statements in this document to reflect any change in its expectations with regard
thereto or any change in events, conditions or circumstances on which any such statement is based or that may affect the likelihood
that actual results will differ from those set forth in the forward-looking statements, unless specifically required by law or
regulation.</I></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Incyte forward looking statements</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Except for the historical information
set forth herein, the matters set forth in this press release contain predictions, estimates and other forward-looking statements,
including without limitation statements regarding: whether the planned transaction will close within the expected timeframe or
ever; whether tafasitamab will be approved for use in humans anywhere or will be commercialized anywhere successfully or at all;
whether the MAA for tafacitinib will be submitted within the expected timeframe or at all; whether tafasitamab or parsaclisib will
be effective in the treatment of the indications discussed in this press release; whether this collaboration will broaden the potential
market for tafasitamab; and whether and when any of the milestone payments or royalties under this collaboration will ever be paid
by Incyte. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially,
including unanticipated developments in and risks related to: obtaining regulatory approval for this planned collaboration; research
and development efforts related to the collaboration programs; the possibility that results of clinical trials may be unsuccessful
or insufficient to meet applicable regulatory standards or warrant continued development; other market or economic factors, including
other scientific developments; unanticipated delays; the effects of market competition; risks associated with relationships between
collaboration partners; the impact of governmental actions regarding pricing, importation and reimbursement for pharmaceuticals;
and such other risks detailed from time to time in each company&rsquo;s reports filed with the Securities and Exchange Commission,
including Incyte&rsquo;s quarterly report on Form 10-Q for the quarter ended September 30, 2019 and MorphoSys&rsquo;s Annual Report
on Form 20-F for the fiscal year ended December 31, 2018. Each party disclaims any intent or obligation to update these forward-looking
statements.</I></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 5</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal"><B>For
more information, please contact:</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal"><B>MorphoSys
AG</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Dr.
        Sarah Fakih</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Vice
        President Corporate Communications &amp; IR</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Tel: +49 (0) 89 / 899 27-26663</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Sarah.Fakih@morphosys.com</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Dr.
        Julia Neugebauer</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Director
        Corporate Communications &amp; IR</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Tel: +49 (0) 89 / 899 27-179</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Julia.Neugebauer@morphosys.com</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Dr.
        Verena Kupas</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Associate
        Director Corporate Communications &amp; IR</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Tel: +49 (0) 89 / 899 27-26814</FONT></P>
        <P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-style: normal">Verena.Kupas@morphosys.com</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">Incyte Corporation</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Catalina Loveman</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Executive Director, Public Affairs</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-left: 9pt">Tel: +1 302 498 6171</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-left: 9pt">cloveman@incyte.com</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-left: 9pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Dr. Michael Booth</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 9pt">Division Vice President, Investor Relations &amp; Corporate Responsibility</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-left: 9pt">Tel: +1 302 498 5914</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-left: 9pt">mbooth@incyte.com</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-left: 9pt">&nbsp;</TD></TR>
</TABLE>




<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 5</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>incy-20200112.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1d -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K85w7xRiXgen8uNbXAsWaWPybPtzp5xWekhuWh5bWnqDy0puycgWyclvk2WwSIB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:incy="http://incyte.com/20200112" elementFormDefault="qualified" targetNamespace="http://incyte.com/20200112">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://incyte.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="incy-20200112_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="incy-20200112_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>incy-20200112_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1d -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>incy-20200112_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1d -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://incyte.com/role/Cover" xlink:href="incy-20200112.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://incyte.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm203494d1_ex99-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm203494d1_ex99-1img002.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !8 'T# 2(  A$! Q$!_\0
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MYI+S5O$OC3Q).DEU]DGU*6YN-,\-VTRZ/HL$RPV\,UP;B]N>&_X)W?L^>*/
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MG0]*FU/PQIDVHZ;J=M877B^+0$U-M.O&TD7RP,1YKXR_;*_9=_X*5>#OV?\
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MC,1A\,Z?;6\OBWQKH=G]B'BW7;'Q)J-\H75-25?[%$_85_8NT[7?AYXIT?\
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M+#QO-=M%<R3*WC70O VA>"=9<RE+_P .^?IEPAAN75NCB+A;AK/\+X'Y!E.
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MOR;B0V['.,9..6/ )+=\CMU-3'M@XYP3[#.?RQ41PK$+QQNP.NXL 1]#@9'
MX],U5:<DE5D.02 H8Y)XR.5/*@A@#@]!C&:^&@XTXP@G.5.'+3]HWS**223K
M5&XJ,DN5RE.*<YN]N:H:.[;:BWJ[V5VNWNKWG;KR[)-MI)VNO]SUY7D?4<_2
MN6\0^(;#P[I-YJNHR>7!$K+$B@M/=S282"UMXE)>2:XE=8XU56;)+$ *<9&O
M>/-+T:<Z9%)<:SKSE%MM!T=%O-2E+@[3<!/W&G0%P5:\U&2V@ #;6<@(<O2?
M"VI:SJ%KXC\;26]Q>6TBS:-H-K+)+IF@EOF$CR$HFI:G&2RO>;!&B_+ "I._
MY'-.(ZN(Q-7)N&(0S'.G^ZJXJ=*=7)^'W*-WB,WQ"DJ?UYPFZ^7Y+2=?'X]T
M%*I'+\OE4QTN"OBYSY\/E_L\1BFU"=524J&!C)-.MB'&[E.*YN3#T^>JZD8*
MK&E2E*90\#^%+Z:]U+QQXGC7_A(== CM[-S\NB:*JHEMIT.%^61HWD,K  L6
MY :64#V5%"J% P   .F, #I^%1M"A)!&003@LV>F/[V#T')'MT J8< #TKU.
M&N'L'PUEE/+<-.MB6ZE;%X['XN4:F.S7-,74=;'YKF%50C]8Q^85Y2JUZS24
M*5+!8.C&GA<#AX+7!82G@L.J%-RDY3G6KU)6YL1B:EO:XFI;_E[5:3DE[L4E
M&%HQ444445]$=1"\ <L2S?,.@( '&.#C<,@#//4 ^H/@OQY_98_9X_:?\,2>
M#OV@_A!X#^+?A\P^3!!XR\/V&H:AIAWEUFT/7$AAUW0;@2'>MQHNI6$BMN*L
M-S9***%:MA,1#%X2M6PN*I3YZ>)PM:KAZ].=*TH2A5H5:-2,HRLU)3NFOM*T
M5,K<MG%25]I)26N^Z?\ DNEC\)_C%_P; ?L#^-M5N==^$OCC]H7X :A*=UMI
M7ASQCHWQ!\*::V!A[6#XH>'_ !%XXMH=X:1+6R^(-M:HQ*PV\2 )7BUI_P &
MS'BW32(=(_X*F_M-:7HP91_9]IX6U:&3R@2/+#VWQG@T]6/S;=FD"%<DK;]<
ME%?I,/'+Q8PN!C27&F/QE*BK4HYO@,@SNK#DA:%L9G'#N8XZ7*HQY/:8NJX6
MO"46W?G_ +-P4O?="*;;;Y95()N]W=1JI:O>R2?;0]D^'_\ P;&?L=17UGJW
M[0GQX_:N_:8N[.YCN+C2?%7Q$LO!WA/4@LC/);7<'AS2W\<I!+N59%L?B#9L
M1YIWEI<K^WW[.G[&/[+G[)>@CP[^SG\$? ?PIM7M4M;W4?#NC0/XGU:%$10-
M<\7:I_:'BK6F9D25SJFKW0>4&1LLS!BBOF<U\1N..,L,J'$7%.=9EA%-5%E]
M7'3I98JD9*TUEN"HY=@%)/X'/"UG25X4G"#<7K#!X:@^:E2A&2N^9)\VJVO*
M4W;7I:Y])_9$"! SH$4*FS: %'95V[>%)0#;@+@#:0K#C]0TOQ3'>74FC^*(
MHHI7\R.SUKP[:ZO;V@.TF*U?3+OP_>FW ;E;NZO)PQ!%Q@%"45\'F=.A&C2D
MZ4KNMSITL1B,+.,ZL&YS4\/.+;]Q64HRA%MN,8-RY]W%5-)2FE:]Z<W3EVMS
M15[=;;7MVL9LME\3&^YXK\&1@+\S+X"UEWZGH'^( 7H<@;3SG)/2LQ/A]JNK
M/(WB?Q]XMU*)P3)8:3_9GA/1R&/SP1C2+0ZV8"HVR1W>N7?F#.YB.***^>67
MX#,,=1PN,AF&+I33FH8K/,YJT%)\T&WAJ>*P-&JG%RBXUG4A*,G&4&M3"I@\
M/5BU5C4JKF22J8BO**M)/X8U**:NKV;MO?F3<7W&C>$]!\/6RVNBZ=!IT?RM
M(]O&@N+B098O=73(UQ<OEF8O-(Y.3V)KH5MTP,,Q'R\?*!P5.<!1@G'.,<$\
M=***^MPF#PF#PU/"X3#4,+AJ*G2I8?#4J="C2@IMM4J=&%*%)2DN>7LU&4IM
MSG4J3<JDZC"$%&$(1A&FWRQA%02;5FVHJ/,VMW-SON[O4L4445V)?UZ72+/_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm203494d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm203494d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !$ ,\# 2(  A$! Q$!_\0
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MW5_$&D_$F;Q%J.F>#-7_ +#TEM7D\/\ Q#B5M=E?YG9(88Y2=_DQY*K]6_\
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MN3DHQK13:;<(IM<KA>)Z*XCS?%87*,(DE*JTYR6[:M%-OKH]6]7O=O5_T/\
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M=7VO?5W/TIG_ .#NO]LM/$WG6_[,_P"S/;^&&O59M!NKWXE#5QIX'4>(%\1
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MLF_MK?M*_LY> _@O^S?X@\)_!WXB7O@WPYK7BZV^)4GB/4-.A31"L^L+X?\
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M\*:3"O\ :7B#Q1XC^#7CC1-#T718QM UKQ!KFJ6UI _S>8TT:%4(WM_GW_\
M!,/_ ()8?\%&?A9_P4._8R^)?Q&_8U^-W@OP#X&_:!\"^)?%OBW7O"J:=I>@
M^&=%U8OK6MZXT98C*,) 0"=AWC(Q7Z=X1YOEN X%\2L%C\XHT*E:*]E3J5:5
M.=:4.$<5%*$)U82G><H)\D9^]62U;2?SG%F%Q>*SC).1-J+N[*32]Z+U:3V2
MM\C\[/\ @K'Q_P %-?\ @H(!T_X:P^.HX]/^$SU\C^0K](/^"] Q\.?^".I!
MY/\ P3 ^#Q/U_P"*>'\@/PKF_P#@I1_P2M_X*._%'_@H!^VO\1?AY^QK\;O&
MW@#QU^T;\8?$WA'Q9X>\+)J6E:]X8U[QAKLFA:SHC%@2'B/F@G#-&5D&%-?>
M'_!9?_@G7^W1\;/!/_!+2Q^$7[+?Q?\ B)?_  F_X)]?##X:_%.U\+:"NHCP
M+XZT6+0&USP?K88C9X@!CD 7&"(7;)!8C]-AQ!D,<9X7\V>X=+#47'$-XC#K
MZO)\#8>BHU+U_P!W>M"5%^T]G[T.3XK1?S?]F8W_ (S"V4/WG[NCU]Z4KK37
M3WO=N];[:GYS^ S_ ,<YW[0X['_@J%\,3^7P8\.?XFOO+_@T57=^VS^U".Q_
M9;@'_F4_#F?_ *]>Y_L??\$>?VNOC)_P1-_:L_97^('PW\0_ +XZ7O[6GAKX
MY_"GPO\ %2T7P]%X['@?X7_#[1O[&+*2?#Z^*XQKGAP^*ER%\6K)/(%@B>1?
MQ!_9[\2?\%4_^".GQJ\;>)?!'[/?Q&^&?Q#\:>#]3^&?B(^/_@7K'C?PSJ.E
M'65U\-H&O(3X8U\-X@T4%7\)>,"C#/+ $5AB<=@>+\E\2>%\ASJC5S[B+BYS
MIP]K%QJQDN#U!N<?:)TYR4X.4/:)*+OK[IOAXXO*L7PAB\<G:SC*RLUO=ZM6
M=FG9ZZI=&?#7@LD_MC^%R?\ H[/21^ ^,^!^@%?=?_!?8 ?\%>OVV0.@\6?#
MX#Z#X*?#_%>P_P#!,?\ X([?MQ_MA_M-?"_XB^,?@]X\^#OP4T+XI>%OB=\1
M?B_\3O"6K^"'U/3="\9IXWUK1/ ^A>(1_P )-K_B#Q:[*N\)_P (8A<.S' -
M?0__  6>_P""9'_!0+XY?\%./VL?BS\(OV2/C3\0_AQXO\4> K[PCXV\-Z#'
MJ7A[7-)@^%WP^\/S'26+ $P^)-#UQ)WSM5C\Q&1GZ&7%7"L>/LHPLL^HPA3X
M+=.I*=:E&,)RGP;)0E.56,(RM3FW"4XS5FW!*YP/+,;_ &,[90Y7DG:SN_=W
MV;\KVMV=S^ES]E+_ ()U?LM?\%#_ /@D9_P33\*?M.>%M>\5:3\-/@GX5\2^
M#+30?%>L^"_L6L:QH1T:9Y#X>GA,@-L%2, @HZ[F8I\@^6_^"GO_  3(_9'_
M ."=?_!(']OL_LN^#_$7A*?XK6GP"_X30:[XTUWQE'?'P5\9?#KZ$D9\133#
M1S$-?UM9)(6*;F50%?*U^BW[*?[1GP2_X)N?\$T_V%/!_P"W7X_TK]F#Q4GP
M>T/P.="^)D.H:?J,7BW0-)\[7-&V:';712>V1TF4,HW++&4^;E?C;_@L-^W;
M^R/^V=_P2!_;@?\ 9;^./@OXTO\ #ZP^"[^-&\*?VF#H4VM?&7PTFBO*=:T
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M.4X.LI0C!3@Y2G&$8\\>:4>:/-]&L+C7G'&+2;4EH[.SNX[.UFVNB^X_(?\
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M>']"76M:UY6\.:'H/A?P_HJA$3_A,O&TCD(JN[**_=?_ (+%_P#!![]IFY^
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M!\4O_4-\,U_/5^PK_P H@_\ @M3_ ->G[''_ *NG7Z_H5_X/"/\ DAO[$_\
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JN6/,M%]KHO\ (EHHHK T"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>8
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm203494-1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm203494-1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "incy-20200112_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "incy-20200112_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "incy-20200112.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "incy",
   "nsuri": "http://incyte.com/20200112",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm203494-1_8k.htm",
      "contextRef": "From2020-01-11to2020-01-12",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://incyte.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm203494-1_8k.htm",
      "contextRef": "From2020-01-11to2020-01-12",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://incyte.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r11": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r13": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r14": {
   "Name": "Forms 20-F, 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220 and 240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm203494-1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://incyte.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm203494-1_8k.htm">tm203494-1_8k.htm</File>
    <File>incy-20200112.xsd</File>
    <File>incy-20200112_lab.xml</File>
    <File>incy-20200112_pre.xml</File>
    <File>tm203494d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>tm203494-1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="incy-20200112.xsd" xlink:type="simple"/>
    <context id="From2020-01-11to2020-01-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000879169</identifier>
        </entity>
        <period>
            <startDate>2020-01-11</startDate>
            <endDate>2020-01-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-01-11to2020-01-12">0000879169</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-01-11to2020-01-12">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2020-01-11to2020-01-12">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-11to2020-01-12">2020-01-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-01-11to2020-01-12">INCYTE CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-01-11to2020-01-12">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-01-11to2020-01-12">001-12400</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-01-11to2020-01-12">94-3136539</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-01-11to2020-01-12">1801 Augustine Cut-Off</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2020-01-11to2020-01-12">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-01-11to2020-01-12">DE</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-01-11to2020-01-12">19803</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-01-11to2020-01-12">302</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-01-11to2020-01-12">498-6700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2020-01-11to2020-01-12">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-01-11to2020-01-12">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-01-11to2020-01-12">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-01-11to2020-01-12">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-01-11to2020-01-12">Common Stock, $.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-01-11to2020-01-12">INCY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-01-11to2020-01-12">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-11to2020-01-12">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M?_C=A'UOW=[]8^.KH&K@UUVH+U!+ P04    "  R@3!0F5R<(Q &  "<)P
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MUM#P0>)S6/$<S.EN?PHO3?*P99TWBISN]F>HQ:#>S@7WOT3Q U!+ P04
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ,H$P4$B-U$[N    *P(  !$
M             ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M,H$P4)E<G",0!@  G"<  !,              ( !M@(  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  R@3!07J\AUJ "  "3"P  &
M    @ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M,H$P4%(1"JQ0 @  U@4  !0              ( !S0L  'AL+W-H87)E9%-T
M<FEN9W,N>&UL4$L! A0#%     @ ,H$P4+JA.8K7 0  ,@8   T
M     ( !3PX  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  R@3!0, /WOC<!
M   B @  #P              @ %1$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ ,H$P4/_ )@B]    A0(  !H              ( !M1$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ ,H$P4 N/V ,A 0
M5P0  !,              ( !JA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      H "@"  @  _!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6632427664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 12, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 12,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INCYTE CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000879169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3136539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1801 Augustine Cut-Off<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">498-6700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INCY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-20-004738-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-20-004738-xbrl.zip
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M-5:!AT4]_=R,+U[S^(U0^@OCKVQ!<,H9B8L[,+;G3MUZM^_E]-ANOIH#B(.
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MH=:'^;\%J%Y<5VO5\>AI\8CE:;S=9JGJ6:4]^#YZ9Y#C!Q0#"F \INB(" C
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M41D4<<'4&7KV6K"N:?WQ*UZ^I/$T2YF@6>P X^>Q&=],N!Z06GUYYW5!6[)
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M$W<39YV^0IKISE\]_?]02P$"% ,4    "  R@3!02+2/S$$#  ")#   $0
M            @ $     :6YC>2TR,#(P,#$Q,BYX<V102P$"% ,4    "  R
M@3!0-@B*BOP*  #?AP  %0              @ %P P  :6YC>2TR,#(P,#$Q
M,E]L86(N>&UL4$L! A0#%     @ ,H$P4"FY*L52!P  ,%D  !4
M     ( !GPX  &EN8WDM,C R,# Q,3)?<')E+GAM;%!+ 0(4 Q0    ( #*!
M,%!1EM-30A@  "M[   1              "  206  !T;3(P,S0Y-"TQ7SAK
M+FAT;5!+ 0(4 Q0    ( #*!,% 2=("7*!P  (%Z   5              "
M 94N  !T;3(P,S0Y-&0Q7V5X.3DM,2YH=&U02P4&      4 !0!' 0  \$H
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
